Prostate Cancer

Interview

ADT Tied to Alzheimer’s Disease, Dementia in Older Patients With Prostate Cancer

08/07/2019

A study led by Ravishankar Jayadevappa, PhD, showed a link between ADT and risk for Alzheimer’s disease/dementia in patients with prostate cancer.

A study led by Ravishankar...

08/07/2019

Oncology

Videos

David Quinn, MD, on the Significance of the ENZAMET Trial in Metastatic Prostate Cancer

06/25/2019

Dr Quinn discusses the significant outcome of a trial evaluating enzalutamide as first-line therapy for men with metastatic prostate cancer.

Dr Quinn discusses the...

06/25/2019

Oncology

Adding Enzalutamide to Standard Care Improves OS in Metastatic Hormone-Sensitive Prostate Cancer

06/11/2019

The addition of enzalutamide to standard of care significantly improved OS in patients with metastatic hormone-sensitive prostate cancer.

The addition of enzalutamide to...

06/11/2019

Oncology

Salvage Radiotherapy Plus Hormone Therapy Improves Survival in Prostate Cancer

06/02/2019

Salvage radiotherapy plus short-term hormone therapy greatly improved survival vs salvage radiotherapy alone in a recent study.

Salvage radiotherapy plus...

06/02/2019

Oncology

Increase in Adverse Events With Enzalutamide Plus Abiraterone and Prednisone for Metastatic CRPC

05/31/2019

Adverse events increased in men with metastatic CRPC treated with enzalutamide plus abiraterone and prednisone.

Adverse events increased in men...

05/31/2019

Oncology

Pembrolizumab–Enzalutamide Combo Shows Sustained Activity in Patients With Metastatic CRPC

05/31/2019

In research being presented at ASCO 2019, pembrolizumab plus enzalutamide demonstrated sustained activity in abiraterone-pretreated, chemotherapy-naïve patients with metastatic CRPC.

In research being presented at...

05/31/2019

Oncology

Increased Fracture Risk With Enzalutamide Plus Ra223 in CRPC Underscores Need for Bone Protection

05/29/2019

Fracture risk significantly increases when Ra223 is added to enzalutamide in asymptomatic patients with metastatic CRPC, according to data presented at ASCO 2019.

Fracture risk significantly...

05/29/2019

Oncology

Carbon Ion Radiotherapy Lowers Risk for Later Primary Cancers in Prostate Cancer

03/26/2019

Patients with localized prostate cancer who receive carbon ion radiotherapy have a lower risk for subsequent primary cancers than recipients of photon radiotherapy.

Patients with localized prostate...

03/26/2019

Oncology

Sequencing Study IDs DNA Repair Genes Tied to Prostate Cancer Risk

03/07/2019

Results from a recent study yielded a panel of 23 genes that could potentially improve treatment pathways for patients with prostate cancer.

Results from a recent study...

03/07/2019

Oncology

Current Guidelines Unreliable for Detecting Germline Variants in Prostate Cancer

02/28/2019

Recent study results suggest that NCCN guidelines are not reliable for identifying patients with prostate cancer based on whether they have pathogenic germline variants.

Recent study results suggest...

02/28/2019

Oncology